Journal of Nanoscience & Nanotechnology Research Open Access

  • Journal h-index: 6
  • Journal CiteScore: 1.44
  • Journal Impact Factor: 1.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Perspective - (2023) Volume 7, Issue 2

Biosynthesis of Eclipta prostrata Nanoparticles: A Promising Approach for Therapeutic Advancements
Adewale Akintelu*
Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, Nigeria
*Correspondence: Adewale Akintelu, Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, Nigeria, Email:

Received: 31-May-2023, Manuscript No. IPNNR-23-16934; Editor assigned: 02-Jun-2023, Pre QC No. IPNNR-23-16934 (PQ); Reviewed: 16-Jun-2023, QC No. IPNNR-23-16934; Revised: 21-Jun-2023, Manuscript No. IPNNR-23-16934 (R); Published: 28-Jun-2023, DOI: 10.12769/IPNNR.23.7.15


In recent years, the field of nanotechnology has emerged as a powerful tool for various applications, including medicine. Nanoparticles synthesized from natural sources offer a sustainable and eco-friendly alternative to traditional synthesis methods. Among the many natural sources, Eclipta prostrata, a medicinal plant with significant therapeutic potential, has garnered attention for its ability to produce nanoparticles with unique properties. This perspective article delves into the biosynthesis of Eclipta prostrata nanoparticles and explores their potential applications in various fields.


Eclipta prostrata and its Medicinal Significance: Eclipta prostrata, commonly known as “False Daisy,” is a medicinal herb found in tropical and subtropical regions. It has been extensively used in traditional medicine for its remarkable healing properties. The plant contains several bioactive compounds, such as wedelolactone, apigenin, and ecliptasaponins, which contribute to its medicinal properties, including anti-inflammatory, antioxidant, and hepatoprotective activities.

Unique Properties of Eclipta prostrata Nanoparticles: The nanoparticles derived from Eclipta prostrata possess several unique properties that make them highly valuable for therapeutic advancements. Their small size, typically ranging from 1 nm to 100 nm, enables better cellular uptake and bioavailability. The surface of these nanoparticles can be easily modified to improve their stability, solubility, and targeting efficiency. Furthermore, their biocompatibility and low toxicity make them suitable for biomedical applications.

Applications in Biomedicine: Eclipta prostrata nanoparticles hold immense potential in various fields of biomedicine. In drug delivery, these nanoparticles can encapsulate therapeutic agents, protecting them from degradation and facilitating controlled release at the target site. Their small size and surface modification capabilities allow for targeted delivery to specific tissues or cells, minimizing off-target effects and enhancing therapeutic efficacy.

Additionally, Eclipta prostrata nanoparticles exhibit antimicrobial properties against a wide range of pathogens, including bacteria, viruses, and fungi. This property makes them suitable for developing novel antimicrobial agents and coatings for medical devices to prevent infections. Furthermore, their antioxidant and anti-inflammatory properties make Eclipta prostrata nanoparticles promising candidates for treating oxidative stress-related disorders, such as neurodegenerative diseases, cardiovascular diseases, and cancer. Their ability to scavenge free radicals and modulate inflammatory responses can potentially alleviate disease progression and improve patient outcomes. Environmental Applications: Beyond biomedicine, Eclipta prostrata nanoparticles have shown promise in environmental applications. Due to their antimicrobial properties, they can be used for water treatment and purification, effectively eliminating microbial contaminants. Moreover, these nanoparticles have the potential to remediate heavy metal pollution in soil and water, offering a sustainable approach to environmental conservation.


The biosynthesis of Eclipta prostrata nanoparticles presents a green and sustainable alternative for the synthesis of nanoparticles with unique properties. With their small size, biocompatibility, and customizable surface characteristics, these nanoparticles hold tremendous potential in biomedicine, ranging from drug delivery systems to antimicrobial agents.

Citation: Akintelu A (2023) Biosynthesis of Eclipta prostrata Nanoparticles: A Promising Approach for Therapeutic Advancements. J Nanosci Nanotechnol. 7:15.

Copyright: © 2023 Akintelu A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.